Management of Hyperkalemia in Patients with Acute Kidney Injury Post Septic Shock: A Case Report
Abstract
Introduction: Hyperkalemia often occurs in patients with acute kidney injury due to decreased ability to excrete potassium. This case report aims to describe treating hyperkalemia in patients with acute kidney injury (AKI) after septic shock. Method: Case reports detailed the management of hyperkalemia correction using a combination of insulin with 40% Dextrose solution, Ca Gluconate, and hemodialysis therapy. Results: A 64-year-old male patient was admitted to the GICU due to septic shock and AKI after undergoing surgery to extract the 36th and 38th teeth accompanied by a retropharyngeal abscess. The physical examination results showed palpitations, tachycardia, hypertension, and grade 1 pitting edema in the upper extremities. The laboratory checks showed hyperkalemia, and an ECG showed sinus tachycardia. The nurse carried out collaborative therapy for potassium correction using a combination of 10-unit insulin and 40% Dextrose, as much as 2 flacons, and Ca Gluconate. Conclusion: Correction of hyperkalemia used a combination of 10-unit insulin and D40%, and Ca Gluconate therapy was the most widely used intervention because it had a rapid onset and hypokalemic effect. Unfortunately, this therapy could not overcome refractory hyperkalemia in these cases, so the patient was advised to undergo hemodialysis therapy.
Full Text:
PDFReferences
Abuelo, J. G. (2015). Low dialysate potassium concentration: an overrated risk factor for cardiac arrhythmia? Seminars in Dialysis, 28(3), 266–275. https://doi.org/10.1111/sdi.12337
Apel, J., Reutrakul, S., & Baldwin, D. (2014). Hypoglycemia in the treatment of hyperkalemia with insulin in patients with end-stage renal disease. Clinical Kidney Journal, 7(3), 248–250. https://doi.org/10.1093/ckj/sfu026
Basile, C., & Lomonte, C. (2015). A neglected issue in dialysis practice: haemodialysate. Clinical Kidney Journal, 8(4), 393–399. https://doi.org/10.1093/ckj/sfv038
Celebi Yamanoglu, N. G., & Yamanoglu, A. (2022). The effect of calcium gluconate in the treatment of hyperkalemia. Turkish Journal of Emergency Medicine, 22(2), 75–82. https://doi.org/10.4103/2452-2473.342812
Chothia, M.-Y., Halperin, M. L., Rensburg, M. A., Hassan, M. S., & Davids, M. R. (2014). Bolus administration of intravenous glucose in the treatment of hyperkalemia: a randomized controlled trial. Nephron. Physiology, 126(1), 1–8. https://doi.org/10.1159/000358836
Coca, A., Valencia, A. L., Bustamante, J., & Mendiluce, A. (2017). Hypoglycemia following intravenous insulin plus glucose for hyperkalemia in patients with impaired renal function. 1–12. https://doi.org/10.5061/dryad.m51q0.Funding
Emmett, M. (2000). Non-dialytic treatment of acute hyperkalemia in the dialysis patient. In Seminars in dialysis (Vol. 13, Issue 5, pp. 279–280). https://doi.org/10.1046/j.1525-139x.2000.00093.x
Evans, T. (2018). Diagnosis and management of sepsis. Clinical Medicine (London, England), 18(2), 146–149. https://doi.org/10.7861/clinmedicine.18-2-146
Fordjour, K. N., Walton, T., & Doran, J. J. (2014). Management of hyperkalemia in hospitalized patients. The American Journal of the Medical Sciences, 347(2), 93–100. https://doi.org/10.1097/MAJ.0b013e318279b105
Gaba, S., Jesrani, G., Gupta, S., & Gupta, M. (2020). Acute Kidney Injury and Hyperkalemia With Precarious Electrocardiographic Changes Caused by Concurrent Use of Telmisartan and Diclofenac. In Cureus (Vol. 12, Issue 8, p. e9858). https://doi.org/10.7759/cureus.9858
Hotchkiss, R. S., Moldawer, L. L., Opal, S. M., Reinhart, K., Turnbull, I. R., & Vincent, J.-L. (2016). Sepsis and septic shock. Nature Reviews. Disease Primers, 2, 16045. https://doi.org/10.1038/nrdp.2016.45
Jung, S.-Y., Kim, H., Park, S., Jhee, J. H., Yun, H.-R., Kim, H., Kee, Y. K., Yoon, C.-Y., Oh, H. J., Chang, T. I., Park, J. T., Yoo, T.-H., Kang, S.-W., Lee, H., Kim, D. K., & Han, S. H. (2016). Electrolyte and mineral disturbances in septic acute kidney injury patients undergoing continuous renal replacement therapy. Medicine, 95(36), e4542. https://doi.org/10.1097/MD.0000000000004542
Kim, H.-J., & Han, S.-W. (2002). Therapeutic approach to hyperkalemia. Nephron, 92 Suppl 1, 33–40. https://doi.org/10.1159/000065375
Ko, C. H., Lan, Y. W., Chen, Y. C., Cheng, T. T., Yu, S. F., Cidem, A., Liu, Y. H., Kuo, C. W., Yen, C. C., Chen, W., & Chen, C. M. (2021). Effects of mean artery pressure and blood ph on survival rate of patients with acute kidney injury combined with acute hypoxic respiratory failure: A retrospective study. Medicina (Lithuania), 57(11). https://doi.org/10.3390/medicina57111243
Kovesdy, C. P. (2014). Management of hyperkalaemia in chronic kidney disease. Nature Reviews. Nephrology, 10(11), 653–662. https://doi.org/10.1038/nrneph.2014.168
Lameire, N., Van Biesen, W., Vanholder, R., & Colardijn, F. (1998). The place of intermittent hemodialysis in the treatment of acute renal failure in the ICU patient. Kidney International. Supplement, 66, S110-9.
Li, T., & Vijayan, A. (2014). Insulin for the treatment of hyperkalemia: a double-edged sword? Clinical Kidney Journal, 7(3), 239–241. https://doi.org/10.1093/ckj/sfu049
Ljutić, D., & Rumboldt, Z. (1993). Should glucose be administered before, with, or after insulin, in the management of hyperkalemia? Renal Failure, 15(1), 73–76. https://doi.org/10.3109/08860229309065576
Mahapatra, S., & Heffner, A. C. (2020). Septic Shock (Treasure Island (FL) (ed.)). StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK430939/
Makris, K., & Spanou, L. (2016). Acute Kidney Injury: Definition, Pathophysiology and Clinical Phenotypes. The Clinical Biochemist. Reviews, 37(2), 85–98.
Martinez-Vea, A., Bardají, A., Garcia, C., & Oliver, J. A. (1999). Severe hyperkalemia with minimal electrocardiographic manifestations: a report of seven cases. Journal of Electrocardiology, 32(1), 45–49. https://doi.org/10.1016/s0022-0736(99)90020-1
McNicholas, B. A., Pham, M. H., Carli, K., Chen, C. H., Colobong-Smith, N., Anderson, A. E., & Pham, H. (2018). Treatment of Hyperkalemia With a Low-Dose Insulin Protocol Is Effective and Results in Reduced Hypoglycemia. Kidney International Reports, 3(2), 328–336. https://doi.org/10.1016/j.ekir.2017.10.009
Montford, J. R., & Linas, S. (2017). How Dangerous Is Hyperkalemia? Journal of the American Society of Nephrology : JASN, 28(11), 3155–3165. https://doi.org/10.1681/ASN.2016121344
Moussavi, K., Fitter, S., Gabrielson, S. W., Koyfman, A., & Long, B. (2019). Management of Hyperkalemia with Insulin and Glucose: Pearls for the Emergency Clinician. Journal of Emergency Medicine, March, 1–7. https://doi.org/10.1016/j.jemermed.2019.03.043
Nguyen, T. Q., Maalouf, N. M., Sakhaee, K., & Moe, O. W. (2011). Comparison of insulin action on glucose versus potassium uptake in humans. Clinical Journal of the American Society of Nephrology : CJASN, 6(7), 1533–1539. https://doi.org/10.2215/CJN.00750111
Ohkuma, T., Harris, K., Cooper, M., Grobbee, D. E., Hamet, P., Harrap, S., Mancia, G., Marre, M., Patel, A., Rodgers, A., Williams, B., Woodward, M., & Chalmers, J. (2022). Short-Term Changes in Serum Potassium and the Risk of Subsequent Vascular Events and Mortality: Results from a Randomized Controlled Trial of ACE Inhibitors. Clinical Journal of the American Society of Nephrology : CJASN, 17(8), 1139–1149. https://doi.org/10.2215/CJN.00180122
Sarnowski, A., Gama, R. M., Dawson, A., Mason, H., & Banerjee, D. (2022). Hyperkalemia in Chronic Kidney Disease: Links, Risks and Management. International Journal of Nephrology and Renovascular Disease, 15, 215–228. https://doi.org/10.2147/IJNRD.S326464
Simon, L., Hashmi, M., & Farrel, M. (2023). Hyperkalemia. In In: StatPearls [Internet]. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK470284/
Sterns, R. H., Grieff, M., & Bernstein, P. L. (2016). Treatment of hyperkalemia: something old, something new. Kidney International, 89(3), 546–554. https://doi.org/10.1016/j.kint.2015.11.018
Watanabe, R. (2020). Hyperkalemia in chronic kidney disease. Revista Da Associacao Medica Brasileira, 66(Suppl 1), 31–36. https://doi.org/10.1590/1806-9282.66.S1.31
WHO. (2023). Sepsis. Factsheets. https://www.who.int/news-room/fact-sheets/detail/sepsis#:~:text=Key facts,all global deaths (1).
Wicaksono, A., Adisasmita, A., & Harijanto, E. (2022). Frekuensi dan Mortalitas Pasien Sepsis dan Syok Septik di ICU Rumah Sakit Swasta Tipe B , di Tangerang Selatan. 6(1), 27–36.
Zeytin, A. T., Çevik, A. A., Nurdan, A., & Özçelik, H. (2010). The effect of calcium gluconate in the treatment of hyperkalemia. Journal of Emergency Medicine Case Reports, 1(1), 41–43.
DOI: https://doi.org/10.24198/pacnj.v4i3.65117
Refbacks
- There are currently no refbacks.
Copyright (c) 2025 Padjadjaran Acute Care Nursing Journal
.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.